Imunon Insider Trades
NASDAQ: IMNNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 6 · $38.15K
- Shares bought / sold
- 0 / 22.39K
- Net activity
- Net selling $38,153
Imunon insider activity
Over the last 12 months, Imunon insiders reported 46 transactions on SEC Form 4: 0 open-market purchases and 6 sales. Insiders bought $0 and sold $38,153 worth of stock, for net insider selling of $38,153. The largest seller was Eylward Susan, with $38,153 in reported sales.
The most recent filing shows Faller Douglas Vincent (Chief Medical Officer) reporting a transaction in 4,390 shares at $1.41 on Sep 25, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IMNN's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
IMNN insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 25, 2026 | Lindborg StacyPresident and CEO | Award | 6,697 | $9.44K | Form 4 |
| Sep 25, 2026 | Tardugno Michael HExecutive Chairman of Board | Award | 7,169 | $10.11K | Form 4 |
| Sep 25, 2026 | Faller Douglas VincentChief Medical Officer | Award | 4,390 | $6.19K | Form 4 |
| Sep 11, 2026 | Tardugno Michael HExecutive Chairman of Board | Award | 5,824 | $8.56K | Form 4 |
| Sep 11, 2026 | Faller Douglas VincentChief Medical Officer | Award | 4,211 | $6.19K | Form 4 |
| Sep 11, 2026 | Lindborg StacyPresident and CEO | Award | 5,504 | $8.09K | Form 4 |
| Aug 31, 2026 | Eylward SusanGeneral Counsel and Corp Sec | Sale | 2,525 | $3.95K | Form 4 |
| Aug 28, 2026 | Eylward SusanGeneral Counsel and Corp Sec | Award | 2,525 | $4.04K | Form 4 |
| Aug 28, 2026 | Faller Douglas VincentChief Medical Officer | Award | 3,626 | $5.80K | Form 4 |
| Aug 28, 2026 | Lindborg StacyPresident and CEO | Award | 6,822 | $10.92K | Form 4 |
| Aug 28, 2026 | Tardugno Michael HExecutive Chairman of Board | Award | 7,371 | $11.79K | Form 4 |
| Aug 17, 2026 | Eylward SusanGeneral Counsel and Corp Sec | Sale | 2,449 | $3.99K | Form 4 |
| Aug 14, 2026 | Tardugno Michael HExecutive Chairman of Board | Award | 7,147 | $11.79K | Form 4 |
| Aug 14, 2026 | Eylward SusanGeneral Counsel and Corp Sec | Award | 2,449 | $4.04K | Form 4 |
| Aug 14, 2026 | Faller Douglas VincentChief Medical Officer | Award | 3,516 | $5.80K | Form 4 |
| Aug 14, 2026 | Lindborg StacyPresident and CEO | Award | 6,615 | $10.91K | Form 4 |
| Aug 3, 2026 | Eylward SusanGeneral Counsel and Corp Sec | Sale | 2,541 | $3.98K | Form 4 |
| Jul 31, 2026 | Lindborg StacyPresident and CEO | Award | 5,010 | $7.97K | Form 4 |
| Jul 31, 2026 | Faller Douglas VincentChief Medical Officer | Award | 3,649 | $5.80K | Form 4 |
| Jul 31, 2026 | Tardugno Michael HExecutive Chairman of Board | Award | 6,358 | $10.11K | Form 4 |
| Jul 31, 2026 | Eylward SusanGeneral Counsel and Corp Sec | Award | 2,541 | $4.04K | Form 4 |
| Jul 31, 2026 | Dentzer James EDirector | Award | 6,934 | $11.03K | Form 4 |
| Jul 31, 2026 | Pellizzari Christine ADirector | Award | 6,934 | $11.03K | Form 4 |
| Jul 31, 2026 | Braun Donald PDirector | Award | 6,180 | $9.83K | Form 4 |
| Jul 31, 2026 | Fritz Frederick J.Director | Award | 6,934 | $11.03K | Form 4 |
| Jul 20, 2026 | Eylward SusanGeneral Counsel and Corp Sec | Sale | 2,150 | $3.83K | Form 4 |
| Jul 17, 2026 | Eylward SusanGeneral Counsel and Corp Sec | Award | 2,150 | $3.93K | Form 4 |
| Jul 17, 2026 | Faller Douglas VincentChief Medical Officer | Award | 3,082 | $5.64K | Form 4 |
| Jul 17, 2026 | Tardugno Michael HExecutive Chairman of Board | Award | 4,603 | $8.42K | Form 4 |
| Jul 17, 2026 | Lindborg StacyPresident and CEO | Award | 4,907 | $8.98K | Form 4 |
| Jul 6, 2026 | Eylward SusanGeneral Counsel and Corp Sec | Sale | 920 | $1.73K | Form 4 |
| Jul 2, 2026 | Lindborg StacyPresident and CEO | Award | 2,534 | $4.84K | Form 4 |
| Jul 2, 2026 | Faller Douglas VincentChief Medical Officer | Award | 1,308 | $2.50K | Form 4 |
| Jul 2, 2026 | Eylward SusanGeneral Counsel and Corp Sec | Award | 920 | $1.76K | Form 4 |
| Jul 2, 2026 | Tardugno Michael HExecutive Chairman of Board | Award | 4,410 | $8.42K | Form 4 |
| Jun 29, 2026 | Eylward SusanGeneral Counsel and Corp Sec | Sale | 11,800 | $20.67K | Form 4 |
| Jun 25, 2026 | Lindborg StacyPresident and CEO | Award | 67,150 | $115.50K | Form 4 |
| Jun 25, 2026 | Faller Douglas VincentChief Medical Officer | Award | 21,896 | $37.66K | Form 4 |
| Jun 25, 2026 | Tardugno Michael HExecutive Chairman of Board | Award | 42,519 | $73.13K | Form 4 |
| Jun 25, 2026 | Eylward SusanGeneral Counsel and Corp Sec | Award | 14,696 | $25.28K | Form 4 |
| Jun 18, 2026 | Lindborg StacyPresident and CEO | Award | 1,803 | $3.28K | Form 4 |
| Jun 18, 2026 | Tardugno Michael HExecutive Chairman of Board | Award | 4,629 | $8.42K | Form 4 |
| Jun 5, 2026 | Lindborg StacyPresident and CEO | Award | 1,593 | $3.28K | Form 4 |
| Jun 5, 2026 | Tardugno Michael HExecutive Chairman of Board | Award | 4,089 | $8.42K | Form 4 |
| May 22, 2026 | Pellizzari Christine ADirector | Award | 5,557 | $12.23K | Form 4 |
| May 22, 2026 | Tardugno Michael HExecutive Chairman of Board | Award | 3,484 | $7.66K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4